Literature DB >> 9565553

Identification and characterization of a novel human aldose reductase-like gene.

D Cao1, S T Fan, S S Chung.   

Abstract

We have identified a novel human protein that is highly homologous to aldose reductase (AR). This protein, which we called ARL-1, consists of 316 amino acids, the same size as AR, and its amino acid sequence is 71% identical to that of AR. It is more closely related to the AR-like proteins such as mouse vas deferens protein, fibroblast growth factor-regulated protein, and Chinese hamster ovary reductase, with 81, 82, and 83%, respectively, of its amino acid sequence identical to the amino acid sequence of these proteins. The cDNA of ARL-1 was expressed in Escherichia coli to obtain recombinant protein for characterization of its enzymatic activities. For comparison, the cDNA of human AR was also expressed in E. coli and analyzed in parallel. These two enzymes differ in their pH optima and salt requirement, but they act on a similar spectrum of substrates. Similar to AR, ARL-1 can efficiently reduce aliphatic and aromatic aldehydes, and it is less active on hexoses. While AR mRNA is found in most tissues studied, ARL-1 is primarily expressed in the small intestines and in the colon, with a low level of its mRNA in the liver. The ability of ARL-1 to reduce various aldehydes and the locations of expression of this gene suggest that it may be responsible for detoxification of reactive aldehydes in the digested food before the nutrients are passed on to other organs. Interestingly, ARL-1 and AR are overexpressed in some liver cancers, but it is not clear if they contribute to the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9565553     DOI: 10.1074/jbc.273.19.11429

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  88 in total

1.  Functional expression of novel human and murine AKR1B genes.

Authors:  Joshua K Salabei; Xiao-Ping Li; J Mark Petrash; Aruni Bhatnagar; Oleg A Barski
Journal:  Chem Biol Interact       Date:  2011-01-27       Impact factor: 5.192

2.  Preparation and characterization of polyclonal antibodies against ARL-1 protein.

Authors:  Jun-Fei Jin; Liu-Di Yuan; Li Liu; Zhu-Jiang Zhao; Wei Xie
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

Review 3.  [Role of transcription factor AP-1 in integration of cellular signalling systems].

Authors:  K T Turpaev
Journal:  Mol Biol (Mosk)       Date:  2006 Nov-Dec

Review 4.  The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.

Authors:  Oleg A Barski; Srinivas M Tipparaju; Aruni Bhatnagar
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

5.  Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions.

Authors:  Kristina A Matkowskyj; Han Bai; Jie Liao; Wanying Zhang; Haonan Li; Sambasiva Rao; Reed Omary; Guang-Yu Yang
Journal:  Hum Pathol       Date:  2013-12-18       Impact factor: 3.466

6.  Structure and promoter characterization of aldo-keto reductase family 1 B10 gene.

Authors:  Ziwen Liu; Linlin Zhong; Paulette A Krishack; Sarah Robbins; Julia X Cao; Yupei Zhao; Stephen Chung; Deliang Cao
Journal:  Gene       Date:  2009-02-21       Impact factor: 3.688

7.  Heat shock protein 90-α mediates aldo-keto reductase 1B10 (AKR1B10) protein secretion through secretory lysosomes.

Authors:  Dixian Luo; Yiwen Bu; Jun Ma; Sandeep Rajput; Yingchun He; Guangxian Cai; Duan-Fang Liao; Deliang Cao
Journal:  J Biol Chem       Date:  2013-11-11       Impact factor: 5.157

8.  Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism.

Authors:  Bernat Crosas; David J Hyndman; Oriol Gallego; Sílvia Martras; Xavier Parés; T Geoffrey Flynn; Jaume Farrés
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

9.  Serum aldo-keto reductase family 1 member B10 predicts advanced liver fibrosis and fatal complications of nonalcoholic steatohepatitis.

Authors:  Masataka Kanno; Kazunori Kawaguchi; Masao Honda; Rika Horii; Hajime Takatori; Tetsuro Shimakami; Kazuya Kitamura; Kuniaki Arai; Taro Yamashita; Yoshio Sakai; Tatsuya Yamashita; Eishiro Mizukoshi; Shuichi Kaneko
Journal:  J Gastroenterol       Date:  2019-02-01       Impact factor: 7.527

Review 10.  Fibrates in the chemical action of daunorubicin.

Authors:  Ganesaratnam K Balendiran
Journal:  Curr Cancer Drug Targets       Date:  2009-05       Impact factor: 3.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.